Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China flag China · Delayed Price · Currency is CNY
49.30
+2.21 (4.69%)
Sep 30, 2026, 4:00 PM EDT

SHE:301096 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
334.9292.6428.97881.931,2392,013
Trading Asset Securities
608083---
Cash & Short-Term Investments
394.9372.6511.97881.931,2392,013
Cash Growth
-30.42%-27.22%-41.95%-28.81%-38.46%1406.49%
Accounts Receivable
963.78902744.4532.18254.49124.41
Other Receivables
10.469.763.164.14.794.1
Receivables
974.24911.77747.56536.28259.28128.5
Inventory
195.23176.44177.3493.1766.0522.85
Prepaid Expenses
----1.83-
Other Current Assets
98.991.28108.6196.443.9461.2
Total Current Assets
1,6631,5521,5451,6081,6102,226
Property, Plant & Equipment
1,7121,7771,8321,7411,075566.63
Long-Term Investments
206.53202.5187.78136.8781.125.77
Other Intangible Assets
88.3389.893.4392.0782.3760.79
Long-Term Accounts Receivable
26.06---1.911.95
Long-Term Deferred Tax Assets
37.7436.8735.5548.4353.4122.86
Long-Term Deferred Charges
1.721.081.420.253.9914.41
Other Long-Term Assets
14.4827.0525.843.1421.626.92
Total Assets
3,7513,6863,7213,6692,9302,925

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
103.4148.7841.82130.25167.0312.64
Accrued Expenses
22.9330.9839.973.444.6954.8
Short-Term Debt
493.09510.61360.08369.32-5.01
Current Portion of Long-Term Debt
195.83169.74104.25--220.32
Current Portion of Leases
0.240.620.730.388.848.8
Current Income Taxes Payable
--0.035.065.736.17
Current Unearned Revenue
83.1576.06112.4274.0162.6171.17
Other Current Liabilities
3.0283.12110.14193.771.893.79
Total Current Liabilities
901.67919.91769.38846.19290.7472.69
Long-Term Debt
284.73189.51244--40.44
Long-Term Leases
0.352.342.920.93-8.14
Long-Term Unearned Revenue
19.8623.7231.4840.671.45-
Long-Term Deferred Tax Liabilities
----4.320.01
Other Long-Term Liabilities
50.1461.8494.0297.17150.9785.83
Total Liabilities
1,2571,1971,142984.97447.45607.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
109.23109.23109.23108.92108.17108.17
Additional Paid-In Capital
2,1092,1072,1072,1272,0612,026
Retained Earnings
324.69323.09413.49498.68313.24183.98
Treasury Stock
-50-50-50-50--
Comprehensive Income & Other
-0.17-0.18-0.14-0.14--
Total Common Equity
2,4922,4892,5792,6842,4832,318
Minority Interest
1.44----0.26-0.14
Shareholders' Equity
2,4942,4892,5792,6842,4822,318
Total Liabilities & Equity
3,7513,6863,7213,6692,9302,925

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
974.23872.82711.99370.648.84282.7
Net Cash (Debt)
-579.34-500.22-200.02511.291,2301,730
Net Cash Growth
----58.43%-28.92%-
Net Cash Per Share
-4.22-4.59-1.864.7211.3421.34
Filing Date Shares Outstanding
108.45108.45108.45108.14108.17108.17
Total Common Shares Outstanding
108.45108.45108.45108.14108.17108.17
Working Capital
761.6632.17776.1761.591,3191,753
Book Value Per Share
22.9822.9523.7824.8222.9521.43
Tangible Book Value
2,4042,3992,4862,5922,4002,257
Tangible Book Value Per Share
22.1722.1222.9223.9722.1920.87
Buildings
986.83980.29863.44859.97196.19196.14
Machinery
1,2271,1941,079629.9642.96319.94
Construction In Progress
70.5266.67206.66448.82546.21104.08